Venlafaxina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Venlafaxina" in Italian language version.

refsWebsite

Global rank Italian rank

29doi.org

2^nd place

7^th place

9nih.gov

4^th place

9^th place

3wiley.com

222^nd place

243^rd place

3sagepub.com

731^st place

1,032^nd place

3springer.com

274^th place

393^rd place

2oadoi.org

799^th place

22^nd place

2psychiatryonline.org

4,032^nd place

3,374^th place

1jamanetwork.com

2,650^th place

2,089^th place

1eurekaselect.com

low place

1tandfonline.com

507^th place

821^st place

1thelancet.com

2,393^rd place

2,216^th place

1elsevier.com

610^th place

820^th place

1archive.org

6^th place

8^th place

1semanticscholar.org

11^th place

2,598^th place

1aap.org

low place

1nature.com

234^th place

226^th place

aap.org

publications.aap.org

(EN) Ema Ferreira, Ana Maria Carceller e Claire Agogué, Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates, in Pediatrics, vol. 119, n. 1, 1º gennaio 2007, pp. 52–59, DOI:10.1542/peds.2006-2133. URL consultato il 30 giugno 2023.

archive.org

A. Einarson, B. Fatoye; M. Sarkar; SV. Lavigne; J. Brochu; C. Chambers; P. Mastroiacovo; A. Addis; D. Matsui; L. Schuler; TR. Einarson, Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study., in Am J Psychiatry, vol. 158, n. 10, ottobre 2001, pp. 1728-30, PMID 11579012.

doi.org

dx.doi.org

(EN) Dale R. Grothe, Brian Scheckner e Dominick Albano, Treatment of Pain Syndromes with Venlafaxine, in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 24, n. 5, 1º maggio 2004, pp. 621–629, DOI:10.1592/phco.24.6.621.34748. URL consultato l'11 novembre 2017.
(EN) Christina E Schober e Nicole T Ansani, Venlafaxine Hydrochloride for the Treatment of Hot Flashes, in Annals of Pharmacotherapy, vol. 37, n. 11, 28 giugno 2016, pp. 1703–1707, DOI:10.1345/aph.1c483. URL consultato l'11 novembre 2017.
(EN) Jari Tiihonen, Jouko Lönnqvist e Kristian Wahlbeck, Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort, in Archives of General Psychiatry, vol. 63, n. 12, 1º dicembre 2006, DOI:10.1001/archpsyc.63.12.1358. URL consultato l'11 novembre 2017.
(EN) Ahmad Ghanizadeh, Roger D. Freeman e Michael Berk, Efficacy and Adverse Effects of Venlafaxine in Children and Adolescents with ADHD: A Systematic Review of Non-controlled and Controlled Trials, in Reviews on Recent Clinical Trials, vol. 8, n. 1, pp. 2–8, DOI:10.2174/1574887111308010002. URL consultato il 30 giugno 2023.
(EN) Chi-Un Pae, Hyun-Kook Lim e Neena Ajwani, Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder, in Expert Review of Neurotherapeutics, vol. 7, n. 6, 2007-06, pp. 603–615, DOI:10.1586/14737175.7.6.603. URL consultato il 30 giugno 2023.
(EN) Nicole J Phelps e Marshall E Cates, The Role of Venlafaxine in the Treatment of Obsessive—Compulsive Disorder, in Annals of Pharmacotherapy, vol. 39, n. 1, 2005-01, pp. 136–140, DOI:10.1345/aph.1E362. URL consultato il 30 giugno 2023.
(EN) Andrea Cipriani, Toshiaki A Furukawa e Georgia Salanti, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, in The Lancet, vol. 373, n. 9665, 28 febbraio 2009, DOI:10.1016/S0140-6736(09)60046-5. URL consultato l'11 novembre 2017.
Michael E. Thase, Anita H. Clayton e Barbara R. Haight, A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability, in Journal of Clinical Psychopharmacology, vol. 26, n. 5, October 2006, pp. 482–488, DOI:10.1097/01.jcp.0000239790.83707.ab. URL consultato l'11 novembre 2017.
(EN) Robert N. Golden e Linda Nicholas, Antidepressant efficacy of venlafaxine ^{[collegamento interrotto]}, in Depression and Anxiety, vol. 12, S1, 1º gennaio 2000, pp. 45–49, DOI:10.1002/1520-6394(2000)12:1+3.0.CO;2-5. URL consultato l'11 novembre 2017.
Pierre Blier, Herbert E. Ward e Philippe Tremblay, Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study, in American Journal of Psychiatry, vol. 167, n. 3, 1º marzo 2010, pp. 281–288, DOI:10.1176/appi.ajp.2009.09020186. URL consultato l'11 novembre 2017.
Eric J. Lenze, Benoit H. Mulsant e Daniel M. Blumberger, Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial, in Lancet (London, England), vol. 386, n. 10011, 12 dicembre 2015, pp. 2404–2412, DOI:10.1016/S0140-6736(15)00308-6. URL consultato l'11 novembre 2017.
(EN) Darren B Courtney, Selective Serotonin Reuptake Inhibitor and Venlafaxine Use in Children and Adolescents with Major Depressive Disorder: A Systematic Review of Published Randomized Controlled Trials, in The Canadian Journal of Psychiatry, vol. 49, n. 8, 2004-08, pp. 557–563, DOI:10.1177/070674370404900807. URL consultato il 30 giugno 2023.
(EN) Xinyu Zhou, Teng Teng e Yuqing Zhang, Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis, in The Lancet Psychiatry, vol. 7, n. 7, 2020-07, pp. 581–601, DOI:10.1016/S2215-0366(20)30137-1. URL consultato il 30 giugno 2023.
WE. Meijer, ER. Heerdink; WA. Nolen; RM. Herings; HG. Leufkens; AC. Egberts, Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants., in Arch Intern Med, vol. 164, n. 21, novembre 2004, pp. 2367-70, DOI:10.1001/archinte.164.21.2367, PMID 15557417.
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J, Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort, in Arch. Gen. Psychiatry, vol. 63, n. 12, 2006, pp. 1358-67, DOI:10.1001/archpsyc.63.12.1358, PMID 17146010.
(EN) Kara N. D. Polen, Sonja A. Rasmussen e Tiffany Riehle-Colarusso, Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007, in Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 97, n. 1, 2013-01, pp. 28–35, DOI:10.1002/bdra.23096. URL consultato il 30 giugno 2023.
(EN) Salvatore Gentile, The Safety of Newer Antidepressants in Pregnancy and Breastfeeding, in Drug Safety, vol. 28, n. 2, 1º febbraio 2005, pp. 137–152, DOI:10.2165/00002018-200528020-00005. URL consultato il 30 giugno 2023.
(EN) Ema Ferreira, Ana Maria Carceller e Claire Agogué, Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates, in Pediatrics, vol. 119, n. 1, 1º gennaio 2007, pp. 52–59, DOI:10.1542/peds.2006-2133. URL consultato il 30 giugno 2023.
Anders Lykkemark Simonsen, Pia Brandt Danborg e Peter Christian Gøtzsche, Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies, in The International Journal of Risk & Safety in Medicine, vol. 28, n. 1, 16 marzo 2016, pp. 1–12, DOI:10.3233/JRS-160668. URL consultato il 30 giugno 2023.
Heli Malm, Alan S. Brown e Mika Gissler, Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study, in Journal of the American Academy of Child & Adolescent Psychiatry, vol. 55, n. 5, 2016-05, pp. 359–366, DOI:10.1016/j.jaac.2016.02.013. URL consultato il 30 giugno 2023.
Ellyn M. Johnson, Ellen Whyte e Benoit H. Mulsant, Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression, in The American Journal of Geriatric Psychiatry, vol. 14, n. 9, 2006-09, pp. 796–802, DOI:10.1097/01.jgp.0000204328.50105.b3. URL consultato il 30 giugno 2023.
(EN) Isabella Pacchiarotti, David J. Bond e Ross J. Baldessarini, The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders, in American Journal of Psychiatry, vol. 170, n. 11, 2013-11, pp. 1249–1262, DOI:10.1176/appi.ajp.2013.13020185. URL consultato il 30 giugno 2023.
(EN) F Bymaster, Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors, in Neuropsychopharmacology, vol. 25, n. 6, 1º dicembre 2001, pp. 871–880, DOI:10.1016/s0893-133x(01)00298-6. URL consultato l'11 novembre 2017.
(EN) Keri Wellington e Caroline M. Perry, Venlafaxine Extended-Release, in CNS Drugs, vol. 15, n. 8, 1º agosto 2001, pp. 643–669, DOI:10.2165/00023210-200115080-00007. URL consultato l'11 novembre 2017.
(EN) J. P. Redrobe, M. Bourin e M. C. Colombel, Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity, in Psychopharmacology, vol. 138, n. 1, 1º luglio 1998, pp. 1–8, DOI:10.1007/s002130050638. URL consultato l'11 novembre 2017.
(EN) Shaul Schreiber, Avi Bleich e Chaim G. Pick, Venlafaxine and mirtazapine, in Journal of Molecular Neuroscience, vol. 18, n. 1-2, 1º febbraio 2002, pp. 143–149, DOI:10.1385/JMN:18:1-2:143. URL consultato l'11 novembre 2017.

doi.org

(EN) Salvatore Gentile, The Safety of Newer Antidepressants in Pregnancy and Breastfeeding, in Drug Safety, vol. 28, n. 2, 1º febbraio 2005, pp. 137–152, DOI:10.2165/00002018-200528020-00005. URL consultato il 30 giugno 2023.
Heli Malm, Alan S. Brown e Mika Gissler, Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study, in Journal of the American Academy of Child & Adolescent Psychiatry, vol. 55, n. 5, 2016-05, pp. 359–366, DOI:10.1016/j.jaac.2016.02.013. URL consultato il 30 giugno 2023.
Ellyn M. Johnson, Ellen Whyte e Benoit H. Mulsant, Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression, in The American Journal of Geriatric Psychiatry, vol. 14, n. 9, 2006-09, pp. 796–802, DOI:10.1097/01.jgp.0000204328.50105.b3. URL consultato il 30 giugno 2023.

elsevier.com

linkinghub.elsevier.com

(EN) Xinyu Zhou, Teng Teng e Yuqing Zhang, Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis, in The Lancet Psychiatry, vol. 7, n. 7, 2020-07, pp. 581–601, DOI:10.1016/S2215-0366(20)30137-1. URL consultato il 30 giugno 2023.

eurekaselect.com

(EN) Ahmad Ghanizadeh, Roger D. Freeman e Michael Berk, Efficacy and Adverse Effects of Venlafaxine in Children and Adolescents with ADHD: A Systematic Review of Non-controlled and Controlled Trials, in Reviews on Recent Clinical Trials, vol. 8, n. 1, pp. 2–8, DOI:10.2174/1574887111308010002. URL consultato il 30 giugno 2023.

jamanetwork.com

archpsyc.jamanetwork.com

(EN) Jari Tiihonen, Jouko Lönnqvist e Kristian Wahlbeck, Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort, in Archives of General Psychiatry, vol. 63, n. 12, 1º dicembre 2006, DOI:10.1001/archpsyc.63.12.1358. URL consultato l'11 novembre 2017.

nature.com

(EN) F Bymaster, Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors, in Neuropsychopharmacology, vol. 25, n. 6, 1º dicembre 2001, pp. 871–880, DOI:10.1016/s0893-133x(01)00298-6. URL consultato l'11 novembre 2017.

nih.gov

ncbi.nlm.nih.gov

Sheik Hosenbocus e Raj Chahal, SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents, in Journal of the Canadian Academy of Child and Adolescent Psychiatry, vol. 20, n. 1, 2011-2, pp. 60–67. URL consultato l'11 novembre 2017.
Michael E. Thase, Anita H. Clayton e Barbara R. Haight, A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability, in Journal of Clinical Psychopharmacology, vol. 26, n. 5, October 2006, pp. 482–488, DOI:10.1097/01.jcp.0000239790.83707.ab. URL consultato l'11 novembre 2017.
Eric J. Lenze, Benoit H. Mulsant e Daniel M. Blumberger, Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial, in Lancet (London, England), vol. 386, n. 10011, 12 dicembre 2015, pp. 2404–2412, DOI:10.1016/S0140-6736(15)00308-6. URL consultato l'11 novembre 2017.
WE. Meijer, ER. Heerdink; WA. Nolen; RM. Herings; HG. Leufkens; AC. Egberts, Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants., in Arch Intern Med, vol. 164, n. 21, novembre 2004, pp. 2367-70, DOI:10.1001/archinte.164.21.2367, PMID 15557417.
FJ. de Abajo, LA. Rodríguez; D. Montero, Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study., in BMJ, vol. 319, n. 7217, ottobre 1999, pp. 1106-9, PMID 10531103.
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J, Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort, in Arch. Gen. Psychiatry, vol. 63, n. 12, 2006, pp. 1358-67, DOI:10.1001/archpsyc.63.12.1358, PMID 17146010.
A. Einarson, B. Fatoye; M. Sarkar; SV. Lavigne; J. Brochu; C. Chambers; P. Mastroiacovo; A. Addis; D. Matsui; L. Schuler; TR. Einarson, Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study., in Am J Psychiatry, vol. 158, n. 10, ottobre 2001, pp. 1728-30, PMID 11579012.

pubmed.ncbi.nlm.nih.gov

R. A. de Moor, L. Mourad e J. ter Haar, [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy], in Nederlands Tijdschrift Voor Geneeskunde, vol. 147, n. 28, 12 luglio 2003, pp. 1370–1372. URL consultato il 30 giugno 2023.
Anders Lykkemark Simonsen, Pia Brandt Danborg e Peter Christian Gøtzsche, Persistent sexual dysfunction after early exposure to SSRIs: Systematic review of animal studies, in The International Journal of Risk & Safety in Medicine, vol. 28, n. 1, 16 marzo 2016, pp. 1–12, DOI:10.3233/JRS-160668. URL consultato il 30 giugno 2023.

oadoi.org

WE. Meijer, ER. Heerdink; WA. Nolen; RM. Herings; HG. Leufkens; AC. Egberts, Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants., in Arch Intern Med, vol. 164, n. 21, novembre 2004, pp. 2367-70, DOI:10.1001/archinte.164.21.2367, PMID 15557417.
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J, Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort, in Arch. Gen. Psychiatry, vol. 63, n. 12, 2006, pp. 1358-67, DOI:10.1001/archpsyc.63.12.1358, PMID 17146010.

psychiatryonline.org

ajp.psychiatryonline.org

Pierre Blier, Herbert E. Ward e Philippe Tremblay, Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study, in American Journal of Psychiatry, vol. 167, n. 3, 1º marzo 2010, pp. 281–288, DOI:10.1176/appi.ajp.2009.09020186. URL consultato l'11 novembre 2017.

psychiatryonline.org

(EN) Isabella Pacchiarotti, David J. Bond e Ross J. Baldessarini, The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders, in American Journal of Psychiatry, vol. 170, n. 11, 2013-11, pp. 1249–1262, DOI:10.1176/appi.ajp.2013.13020185. URL consultato il 30 giugno 2023.

sagepub.com

journals.sagepub.com

(EN) Christina E Schober e Nicole T Ansani, Venlafaxine Hydrochloride for the Treatment of Hot Flashes, in Annals of Pharmacotherapy, vol. 37, n. 11, 28 giugno 2016, pp. 1703–1707, DOI:10.1345/aph.1c483. URL consultato l'11 novembre 2017.
(EN) Nicole J Phelps e Marshall E Cates, The Role of Venlafaxine in the Treatment of Obsessive—Compulsive Disorder, in Annals of Pharmacotherapy, vol. 39, n. 1, 2005-01, pp. 136–140, DOI:10.1345/aph.1E362. URL consultato il 30 giugno 2023.
(EN) Darren B Courtney, Selective Serotonin Reuptake Inhibitor and Venlafaxine Use in Children and Adolescents with Major Depressive Disorder: A Systematic Review of Published Randomized Controlled Trials, in The Canadian Journal of Psychiatry, vol. 49, n. 8, 2004-08, pp. 557–563, DOI:10.1177/070674370404900807. URL consultato il 30 giugno 2023.

semanticscholar.org

(EN) P. Broy e A. Bérard, Gestational exposure to antidepressants and the risk of spontaneous abortion: a review., in Current drug delivery, 2010. URL consultato il 30 giugno 2023.

springer.com

link.springer.com

(EN) Keri Wellington e Caroline M. Perry, Venlafaxine Extended-Release, in CNS Drugs, vol. 15, n. 8, 1º agosto 2001, pp. 643–669, DOI:10.2165/00023210-200115080-00007. URL consultato l'11 novembre 2017.
(EN) J. P. Redrobe, M. Bourin e M. C. Colombel, Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity, in Psychopharmacology, vol. 138, n. 1, 1º luglio 1998, pp. 1–8, DOI:10.1007/s002130050638. URL consultato l'11 novembre 2017.
(EN) Shaul Schreiber, Avi Bleich e Chaim G. Pick, Venlafaxine and mirtazapine, in Journal of Molecular Neuroscience, vol. 18, n. 1-2, 1º febbraio 2002, pp. 143–149, DOI:10.1385/JMN:18:1-2:143. URL consultato l'11 novembre 2017.

tandfonline.com

(EN) Chi-Un Pae, Hyun-Kook Lim e Neena Ajwani, Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder, in Expert Review of Neurotherapeutics, vol. 7, n. 6, 2007-06, pp. 603–615, DOI:10.1586/14737175.7.6.603. URL consultato il 30 giugno 2023.

thelancet.com

(EN) Andrea Cipriani, Toshiaki A Furukawa e Georgia Salanti, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, in The Lancet, vol. 373, n. 9665, 28 febbraio 2009, DOI:10.1016/S0140-6736(09)60046-5. URL consultato l'11 novembre 2017.

wiley.com

onlinelibrary.wiley.com

(EN) Dale R. Grothe, Brian Scheckner e Dominick Albano, Treatment of Pain Syndromes with Venlafaxine, in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 24, n. 5, 1º maggio 2004, pp. 621–629, DOI:10.1592/phco.24.6.621.34748. URL consultato l'11 novembre 2017.
(EN) Robert N. Golden e Linda Nicholas, Antidepressant efficacy of venlafaxine ^{[collegamento interrotto]}, in Depression and Anxiety, vol. 12, S1, 1º gennaio 2000, pp. 45–49, DOI:10.1002/1520-6394(2000)12:1+3.0.CO;2-5. URL consultato l'11 novembre 2017.
(EN) Kara N. D. Polen, Sonja A. Rasmussen e Tiffany Riehle-Colarusso, Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007, in Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 97, n. 1, 2013-01, pp. 28–35, DOI:10.1002/bdra.23096. URL consultato il 30 giugno 2023.